Unruly Republic: Columnist Barton Swaim argues that Democrats' response to President Trump's attack on Iran is motivated by the Iraq war, appeasing the progressive left, but ultimately brings us back ...

Mobile home park investing lies at the crossroads of affordable housing and operationally heavy real estate. From my time leading a mobile home park investment company, I’ve concluded that success as ...

Watched One Piece Season 2 in an absolute frenzy and worry you missed key moments? Relatable. Here’s a quick recap of how the season ended, plus the biggest unanswered questions we have going into ...

Discover the surprising things I learned the hard way on my first cruise! From hidden tips to unexpected experiences, this video is perfect for first-time cruisers looking to prepare and make the most ...

When it comes to new takes on iconic IPs and stories from the nerd culture sphere, it can be easy to be a stickler for accuracy. Beloved IPs are usually, well, beloved for a reason, and the idea of ...

US President Donald Trump has appointed 13 people to his panel of science advisers — and all but one is a leading technology executive. The President’s Council of Advisors on Science and Technology ...

Joe Tracz also discusses working with season three’s new co-showrunner Ian Stokes and how they’re approaching adapting the massive manga season-by-season. By Abbey White Associate Editor & News Writer ...

#1 App for Anyone Who Wants To change Their Life 🥋 Become a member and join the Absolute Motivation inner circle; your support will never be forgotten. If you found this video enjoyable, kindly show ...

Celebrate Pi Day and read about how this number pops up across math and science on our special Pi Day page. For more than two millennia, mathematicians have produced a growing heap of pi equations in ...

Make this your preferred source to get more updates from this publisher on Google. Warning: Minor spoilers for "One Piece: Into the Grand Line" ahead. One thing that most "One Piece" fans can agree on ...

Every time Sinéad publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...